On June 28, the Guangdong provincial key construction projects - Heyou Hospital and Heyou Hospital IMC officially opened in Foshan Sanlongwan Sci-Tech City, providing comprehensive and high-level medical services to a wide range of patients.
Exterior of Heyou Hospital
Early in the morning, many citizens came to Heyou Hospital for medical consultations. Heyou Hospital is a non-profit tertiary comprehensive hospital, offering medical services priced comparably to public tertiary hospitals, thus providing patients with high-quality medical care at affordable prices and alleviating the burden of medical expenses. The hospital's outpatient, inpatient, and maternity services are covered under medical insurance, allowing citizens to enjoy reimbursement benefits. As a non-profit hospital, all future revenue surplus will be used for hospital development, medical research, and social welfare.
Citizens seeking medical treatment and consultations at Heyou Hospital
Heyou Hospital IMC with world-class hospital standards, is positioned as an international high-end medical institution. It offers direct payment services through commercial insurance, which can meet the diverse and multi-level medical needs of patients.
Notably, Heyou Hospital focuses on regional disease profiles and medical demands, with special emphasis on Centers of Excellence (COEs) such as Oncology, Neurology and Neurosurgery, Orthopedics and Sports Medicine, Cardiovascular Medicine, Maternal and Child Health, and Health Management. The hospital now has established 46 departments.
Interior of Heyou Hospital
The hospital's department heads are top clinical experts from China's top 100 hospitals, covering fields such as Oncology, Orthopedics and Sports Medicine, Nuclear Medicine, Neurology and Brain Sciences, bringing extensive clinical experience and profound academic achievements. Additionally, several experts and professors from renowned medical centers overseas are part of the team, including chief scientists of key research and development programs by the Ministry of Science and Technology and outstanding academic/technical leaders.
The Heyou Proton and Heavy Ion Center is set to open in 2026
Recently, the highly anticipated Heyou Proton and Heavy Ion Center has made significant progress. On May 28th, the core components of the integrated proton and heavy ion equipment were successfully installed for the first time. The center is expected to be completed by 2026 and commence clinical trials, further enhancing the precision treatment capabilities for tumors in the Guangdong-Hong Kong-Macao Greater Bay Area.
Planning diagram of Heyou Proton and Heavy Ion Center
Lu Jiade, Vice President of Heyou Hospital and Director of the Oncology Medical Center and Proton and Heavy Ion Center, introduced, "Proton and heavy ion technologies are internationally recognized as cutting-edge cancer radiotherapy methods, offering precise treatment for various solid tumors with shorter treatment cycles and fewer side effects. They are particularly suitable for prevalent cancers in Guangdong Province, such as nasopharyngeal carcinoma and lung cancer.”
This equipment is among the few globally equipped with both proton rotation gantry and multiple-angle heavy ion treatment capabilities, making it one of the world's leading configurations in terms of radiation types and treatment angles, both currently and for a considerable time after its completion.
In addition, the Heyou Center of Excellence in Oncology (COE) is also under concurrent accelerated construction. Apart from the Proton and Heavy Ion Center, the Oncology Medical Center will also conduct tumor drug therapy, photon radiotherapy, tumor surgical treatment, etc. By introducing outstanding clinical oncology, medical physics, and technical talents, as well as advanced diagnostic and treatment equipment and technologies, it aims to create a cutting-edge and high-end platform for cancer prevention and treatment.
Reporter | Eleanor
Revisor | Lynn, Zoey
Photo | Foshan Daily, Nanfang Plus
*If the picture infringes any rights, please contact us for deletion.